Clinical Trial Update: Alfuzosin Treatment in Children and Adolescents With Hydronephrosis of Neuropathic Etiology [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating alfuzosin in children and adolescents with hydronephrosis of neurogenic etiology completed; results were posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hydronephrosis
• Neurogenic Bladder

Drugs mentioned

• Alfuzosin (alfuzosin)

Snippet

Sponsor: Sanofi | Conditions: Hydronephrosis, Neurogenic Bladder | Phase 3 | Status: COMPLETED | Results posted: 2011-02-08